GSK already has a liver-focused siRNA candidate in the clinic in the form of gatuzosiran. (Sheldon Cooper/SOPA Images/LightRocket via Getty Images) GSK is paying Wave Life Sciences $12 million upfront ...

When light or sound bounces around inside an oddly shaped room, its reflections can quickly become difficult to predict. But new research led by scientists at the Advanced Science Research Center at ...

WVE-007 induces fat loss without muscle loss, with clinical data supporting 1-2x per year dosing; preclinical data demonstrate Wave’s INHBE GalNAc-siRNA in combination with GLP-1 doubled weight loss ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The whole planet is warming, but changes in weather patterns could help explain why the continent is suffering so many bouts of severe heat. By Raymond Zhong Reporting from London Europe is sweating ...

Wave Life Sciences has lost nearly 70% of its value this year, yet its RNA platform spans obesity, rare liver disease, and genetic disorders in ways that could make it irresistible to the right buyer.

Wave Life Sciences trades at 2.45x cash with a $1.2B market cap and no debt but faces intense competition across its RNA therapy pipeline. WVE-007 failed to meet FDA obesity drug benchmarks, causing a ...

Harvard’s Faculty of Arts and Sciences directly laid off 75 staff across its social sciences units last week — nearly one-third of employees covered by the restructuring and more than twice the number ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. The Redomiciliation was completed after the close of ...